Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.

Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression.
复制标题

DOI:
10.18632/oncotarget.3072
复制
发表时间:
2015-02-20
期刊:
影响因子:
--
通讯作者:
Côté J
Côté J
中科院分区:
其他
文献类型:
--
作者:
Baldwin RM;Haghandish N;Daneshmand M;Amin S;Paris G;Falls TJ;Bell JC;Islam S;Côté J

文献摘要

参考文献

被引文献

相似文献

最近的证据表明,蛋白质精氨酸甲基转移酶 (PRMT) 家族在癌症中发挥着关键作用。多项基因表达研究已发现 PRMT7 与乳腺癌患者的转移增加和生存率降低有关。然而,这尚未得到广泛研究。在这里,我们报告 PRMT7 表达在原发性乳腺肿瘤组织和乳腺癌淋巴结转移中显着上调。我们已经证明,使用 RNA 干扰降低侵袭性乳腺癌细胞中 PRMT7 的水平可显着减少体外细胞侵袭和体内转移。相反,非攻击性MCF7细胞中PRMT7的过度表达增强了它们的侵袭性。此外,我们发现 PRMT7 诱导基质金属蛋白酶 9 (MMP9) 的表达,MMP9 是众所周知的乳腺癌转移介质。重要的是,我们通过外源表达 MMP9 显着挽救了 PRMT7 耗尽的侵袭性乳腺癌细胞的侵袭。我们的结果表明,乳腺癌中 PRMT7 的上调可能通过调节 MMP9 在促进细胞侵袭中发挥重要作用。这表明 PRMT7 是乳腺癌的一种新型且潜在重要的生物标志物和治疗靶点。
Recent evidence points to the protein arginine methyltransferase (PRMT) family of enzymes playing critical roles in cancer. PRMT7 has been identified in several gene expression studies to be associated with increased metastasis and decreased survival in breast cancer patients. However, this has not been extensively studied. Here we report that PRMT7 expression is significantly upregulated in both primary breast tumour tissues and in breast cancer lymph node metastases. We have demonstrated that reducing PRMT7 levels in invasive breast cancer cells using RNA interference significantly decreased cell invasion in vitro and metastasis in vivo. Conversely, overexpression of PRMT7 in non-aggressive MCF7 cells enhanced their invasiveness. Furthermore, we show that PRMT7 induces the expression of matrix metalloproteinase 9 (MMP9), a well-known mediator of breast cancer metastasis. Importantly, we significantly rescued invasion of aggressive breast cancer cells depleted of PRMT7 by the exogenous expression of MMP9. Our results demonstrate that upregulation of PRMT7 in breast cancer may have a significant role in promoting cell invasion through the regulation of MMP9. This identifies PRMT7 as a novel and potentially significant biomarker and therapeutic target for breast cancer.
DOI: 10.1042/bj20120768
发表时间: 2012-09-01
期刊: The Biochemical journal
影响因子: --
作者:
Gu Z;Gao S;Zhang F;Wang Z;Ma W;Davis RE;Wang Z
通讯作者: Wang Z
DOI: 10.1016/s1046-2023(03)00032-x
发表时间: 2003-07-01
期刊: METHODS
影响因子: 4.8
作者:
Debnath, J;Muthuswamy, SK;Brugge, JS
通讯作者: Brugge, JS
DOI: 10.1074/jbc.m704349200
发表时间: 2007-11-09
影响因子: 4.8
作者:
Goulet, Isabelle;Gauvin, Gabrielle;Cote, Jocelyn
通讯作者: Cote, Jocelyn
DOI: 10.1038/sj.bjc.6604181
发表时间: 2008-02-12
影响因子: 8.8
作者:
D'Arcy, V.;Pore, N.;Docquier, F.;Abdullaev, Z. K.;Chernukhin, I.;Kita, G-X;Rai, S.;Smart, M.;Farrar, D.;Pack, S.;Lobanenkov, V.;Klenova, E.
通讯作者: Klenova, E.
DOI: 10.1158/0008-5472.can-11-3498
发表时间: 2012-06-15
期刊: Cancer research
影响因子: 11.2
作者:
David JM;Rajasekaran AK
通讯作者: Rajasekaran AK